LYCERA CORP
Profile
Company Names
LYCERA CORP
Addresses
2800 PLYMOUTH ROAD, NCRC, BUILDING 26, ANN ARBOR, MI 48109
2800 PLYMOUTH ROAD, NCRC, BUILDING 26, ANN ARBOR, MI 48109
2800 PLYMOUTH RD., NCRC, BUILDING 26, ANN ARBOR, MI 48109
2800 PLYMOUTH ROARD, NCRC, BUILDING 26, ANN ARBOR, MI 48109
46701 N. COMMERCE CENTER DR., SUITE C, PLYMOUTH, MI 48170
Phone Numbers
(734) 764-4548
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$72,810,304.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2015-06-12
$29,892,748.00
INDEFINITE
INDEFINITE
Equity, Debt
3
2014-03-21
$4,000,000.00
$9,183,393.00
$5,183,393.00
Debt
2
2013-10-11
$5,000,000.00
$5,739,621.00
$739,621.00
Debt
1
2009-04-07
$33,917,556.00
$38,917,556.00
$5,000,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KRISTINA
BUROW
DIRECTOR
KILIMANJARO ENERGY, INC.
| LIMERICK BIOPHARMA INC
| RECEPTOS, INC.
| TRELYS, INC.
| CENEXYS, INC.
| LYCERA CORP
| ARCH VENTURE FUND VIII, L.P.
| AGBIOME, LLC
| METACRINE, INC.
| SIENNA LABS, INC.
| SCHOLAR ROCK LLC
| UNITY BIOTECHNOLOGY, INC.
| ARCH VENTURE FUND IX, L.P.
| BORAGEN, INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| VIVIDION THERAPEUTICS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| BOUNDLESS BIO, INC.
| ARCH VENTURE FUND XI, L.P.
| TREELINE BIOSCIENCES, INC.
| ARCH VENTURE FUND XII, L.P.
| NEUMORA THERAPEUTICS, INC.
| MIRADOR THERAPEUTICS, INC.
| AUTOBAHN THERAPEUTICS, INC.
| METSERA, INC.
STEVE
GILLIS
DIRECTOR
XORI CORP
| ONCOFACTOR CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| LYCERA CORP
| VBI VACCINES INC.
| ONCORESPONSE INC
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| APOGEN BIOTECHNOLOGIES, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| MAGNOLIA NEUROSCIENCES CORP
| VBI VACCINES INC/BC
| ALLY THERAPEUTICS, INC.
| SKYLARK BIO, INC.
| BASKING BIOSCIENCES, INC.
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
GARY
GLICK
EXECUTIVE OFFICER, DIRECTOR
MICHAEL
HAYDEN
DIRECTOR
ROBERT
KAMEN
DIRECTOR
NINA
KJELLSON
DIRECTOR
LYCERA CORP
| PRIMERA BIOSYSTEMS INC
| PRIMERADX, INC.
| ALVINE PHARMACEUTICALS INC
| SEQUEL PHARMACEUTICALS INC
| CNS THERAPEUTICS INC
| TRIUS THERAPEUTICS INC
| CEBIX INCOPRATED
| CEBIX INC
| EIGER BIOPHARMACEUTICALS INC
| OCERA THERAPEUTICS INC
| WELLTOK, INC.
| OCERA THERAPEUTICS, INC.
| K2 THERAPEUTICS, INC.
| CIDARA THERAPEUTICS, INC.
| EIGER BIOPHARMACEUTICALS, INC.
| ANNUM HEALTH, INC.
| VINETI, INC.
| TYRA BIOSCIENCES, INC.
JEFFREY
LEIDEN
DIRECTOR
KATHLEEN
M.
METTERS
EXECUTIVE OFFICER, DIRECTOR
PAUL
SEKHRI
EXECUTIVE OFFICER
MICHAEL
STEINMETZ
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

